Article Figures & Data
Tables
- Table 1:
Demographic and laboratory results in African American–Diabetes Heart Study MIND participants (N = 263)
Variable Mean SD Age (yr) 60.4 9.6 Duration of diabetes (yr) 14.3 8.9 Age of diabetes diagnosis (yr) 46.0 11.0 Body mass index (kg/m2) 34.1 7.9 Glucose (mg/dL) 147.5 60.3 HbA1c (%) 8.2 2.1 LDL cholesterol (mg/dL) 109.1 37.7 HDL cholesterol (mg/dL) 47.2 11.9 Triglycerides (mg/dL) 115.7 72.3 Systolic blood pressure (mm Hg) 131.2 18.6 Diastolic blood pressure (mm Hg) 75.4 10.8 Thyroid stimulating hormone (μIU/mL) 2.0 1.6 Vitamin B12 (pg/mL) 690.0 417.3 Note:—LDL indicates low-density lipoprotein; HDL, high-density lipoprotein.
Variable No. (% of Total Cohort) Female 165 (62.7%) Hypertension 87 (33.1%) Insulin use 108 (41.1%) Lipid medication 93 (54.7%) Smoking Never 117 (44.7%) Former 91 (34.7%) Current 54 (20.6%) Education Less than a high school diploma 27 (10.3%) High school diploma 76 (28.9%) Some college or a college diploma 115 (43.7%) Graduate education 45 (17.1%) - Table 3:
MRI and cognitive function measures in African American–Diabetes Heart Study MIND
Variable Mean SD No. MRI results GM volume, unadjusted (mL) 732.2 57.7 263 GM/ICV (%)a 43.3 2.8 263 WM volume, unadjusted (mL) 629.6 46.7 263 WM/ICV (%)a 37.3 2.3 263 WM lesion volume (mL) 7.9 14.7 263 Cognitive function measures 3MSE (score, 0–100) 84.6 9.0 256 MoCA (score, 0–30) 19.9 3.9 261 RAVLT (score, 0–75) 38.0 9.0 263 DSC (score, 0–133) 48.1 15.9 262 VFA 15.7 4.6 262 Stroop errors 3.4 6.3 258 Stroop interference (seconds; trial 3 to trial 2) 31.6 16.1 256 CESD 8.0 5.3 262 BSI-Anxiety 4.9 4.5 262 Note:—ICV indicates intracranial volume; 3 MSE, modified MMSE; RAVLT, Rey Auditory Verbal Learning Test; CESD, Center for Epidemiologic Studies Depression Scale; BSI-Anxiety, Brief Symptom Inventory.
↵a Whole-brain measures adjusted for total ICV.
